
HV.1 Variant Takes Over as U.S. Booster Program Falls Behind
The HV.1 variant of the coronavirus, a mutation of the EG.5 variant, has become dominant in the United States, accounting for 25% of cases. Experts say it is more transmissible but not more likely to cause severe disease. While concerns are raised over America's slow booster vaccine program, with less than 3% of Americans having received a booster shot, Covid cases and hospitalizations are currently declining. However, experts warn that colder weather and upcoming holiday gatherings could lead to an increase in cases. The HV.1 variant has been detected in over 41 countries, including the UK, Canada, and Israel, and has several mutations on its spike protein. The US is rolling out an updated booster vaccine based on the XBB.1.5 variant, which experts believe will still be effective against HV.1.



